Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 1722 entries
Sorted by: Best Match Show Resources per page
Gastroesophageal Reflux Symptoms After Laparoscopic Sleeve Gastrectomy for Morbid Obesity. The Importance of Preoperative Evaluation and Selection.

North American journal of medical sciences

Sucandy I, Chrestiana D, Bonanni F, Antanavicius G.
PMID: 26110129
N Am J Med Sci. 2015 May;7(5):189-93. doi: 10.4103/1947-2714.157624.

BACKGROUND: Gastroesophageal reflux disease (GERD) is prevalent in morbidly obese patients, and its severity appears to correlate with body mass index (BMI).AIM: The aim of this study is to investigate the status of GERD after laparoscopic sleeve gastrectomy (LSG).MATERIALS...

Cite
Sucandy I, Chrestiana D, Bonanni F, et al. Gastroesophageal Reflux Symptoms After Laparoscopic Sleeve Gastrectomy for Morbid Obesity. The Importance of Preoperative Evaluation and Selection. N Am J Med Sci. 2015;7(5):189-93doi: 10.4103/1947-2714.157624.
Sucandy, I., Chrestiana, D., Bonanni, F., & Antanavicius, G. (2015). Gastroesophageal Reflux Symptoms After Laparoscopic Sleeve Gastrectomy for Morbid Obesity. The Importance of Preoperative Evaluation and Selection. North American journal of medical sciences, 7(5), 189-93. https://doi.org/10.4103/1947-2714.157624
Sucandy, Iswanto, et al. "Gastroesophageal Reflux Symptoms After Laparoscopic Sleeve Gastrectomy for Morbid Obesity. The Importance of Preoperative Evaluation and Selection." North American journal of medical sciences vol. 7,5 (2015): 189-93. doi: https://doi.org/10.4103/1947-2714.157624
Sucandy I, Chrestiana D, Bonanni F, Antanavicius G. Gastroesophageal Reflux Symptoms After Laparoscopic Sleeve Gastrectomy for Morbid Obesity. The Importance of Preoperative Evaluation and Selection. N Am J Med Sci. 2015 May;7(5):189-93. doi: 10.4103/1947-2714.157624. PMID: 26110129; PMCID: PMC4462813.
Copy Download .nbib Format: NLM
Proton Pump Inhibitors In South Africa: Role Of Branded Generics.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Truter I.
PMID: 27200753
Value Health. 2014 Nov;17(7):A364. doi: 10.1016/j.jval.2014.08.806. Epub 2014 Oct 26.

No abstract available.

Cite
Truter I. Proton Pump Inhibitors In South Africa: Role Of Branded Generics. Value Health. 2014;17(7):A364doi: 10.1016/j.jval.2014.08.806.
Truter, I. (2014). Proton Pump Inhibitors In South Africa: Role Of Branded Generics. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A364. https://doi.org/10.1016/j.jval.2014.08.806
Truter, I. "Proton Pump Inhibitors In South Africa: Role Of Branded Generics." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A364. doi: https://doi.org/10.1016/j.jval.2014.08.806
Truter I. Proton Pump Inhibitors In South Africa: Role Of Branded Generics. Value Health. 2014 Nov;17(7):A364. doi: 10.1016/j.jval.2014.08.806. Epub 2014 Oct 26. PMID: 27200753.
Copy Download .nbib Format: NLM
Concomitant Use of Non-Steroidal Anti-Inflammatory Drugs (Nsaids) And Proton Pump Inhibitors (Ppis) in Newly Diagnosed Patients With Osteoarthritis (Oa), Rheumatoid Arthritis (Ra) or Ankylosing Spondylitis (As).

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Dziarmaga A, Reidel K, White R, Tarride JE, Corner N.
PMID: 27200896
Value Health. 2014 Nov;17(7):A390. doi: 10.1016/j.jval.2014.08.2666. Epub 2014 Oct 26.

No abstract available.

Cite
Dziarmaga A, Reidel K, White R, et al. Concomitant Use of Non-Steroidal Anti-Inflammatory Drugs (Nsaids) And Proton Pump Inhibitors (Ppis) in Newly Diagnosed Patients With Osteoarthritis (Oa), Rheumatoid Arthritis (Ra) or Ankylosing Spondylitis (As). Value Health. 2014;17(7):A390doi: 10.1016/j.jval.2014.08.2666.
Dziarmaga, A., Reidel, K., White, R., Tarride, J. E., & Corner, N. (2014). Concomitant Use of Non-Steroidal Anti-Inflammatory Drugs (Nsaids) And Proton Pump Inhibitors (Ppis) in Newly Diagnosed Patients With Osteoarthritis (Oa), Rheumatoid Arthritis (Ra) or Ankylosing Spondylitis (As). Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A390. https://doi.org/10.1016/j.jval.2014.08.2666
Dziarmaga, A, et al. "Concomitant Use of Non-Steroidal Anti-Inflammatory Drugs (Nsaids) And Proton Pump Inhibitors (Ppis) in Newly Diagnosed Patients With Osteoarthritis (Oa), Rheumatoid Arthritis (Ra) or Ankylosing Spondylitis (As)." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A390. doi: https://doi.org/10.1016/j.jval.2014.08.2666
Dziarmaga A, Reidel K, White R, Tarride JE, Corner N. Concomitant Use of Non-Steroidal Anti-Inflammatory Drugs (Nsaids) And Proton Pump Inhibitors (Ppis) in Newly Diagnosed Patients With Osteoarthritis (Oa), Rheumatoid Arthritis (Ra) or Ankylosing Spondylitis (As). Value Health. 2014 Nov;17(7):A390. doi: 10.1016/j.jval.2014.08.2666. Epub 2014 Oct 26. PMID: 27200896.
Copy Download .nbib Format: NLM
Laryngopharyngeal reflux: diagnosis, treatment, and latest research.

International archives of otorhinolaryngology

Campagnolo AM, Priston J, Thoen RH, Medeiros T, Assunção AR.
PMID: 25992088
Int Arch Otorhinolaryngol. 2014 Apr;18(2):184-91. doi: 10.1055/s-0033-1352504. Epub 2013 Nov 05.

Introduction Laryngopharyngeal reflux (LPR) is a highly prevalent disease and commonly encountered in the otolaryngologist's office. Objective To review the literature on the diagnosis and treatment of LPR. Data Synthesis LPR is associated with symptoms of laryngeal irritation such...

Cite
Campagnolo AM, Priston J, Thoen RH, et al. Laryngopharyngeal reflux: diagnosis, treatment, and latest research. Int Arch Otorhinolaryngol. 2013;18(2):184-91doi: 10.1055/s-0033-1352504.
Campagnolo, A. M., Priston, J., Thoen, R. H., Medeiros, T., & Assunção, A. R. (2014). Laryngopharyngeal reflux: diagnosis, treatment, and latest research. International archives of otorhinolaryngology, 18(2), 184-91. https://doi.org/10.1055/s-0033-1352504
Campagnolo, Andrea Maria, et al. "Laryngopharyngeal reflux: diagnosis, treatment, and latest research." International archives of otorhinolaryngology vol. 18,2 (2014): 184-91. doi: https://doi.org/10.1055/s-0033-1352504
Campagnolo AM, Priston J, Thoen RH, Medeiros T, Assunção AR. Laryngopharyngeal reflux: diagnosis, treatment, and latest research. Int Arch Otorhinolaryngol. 2014 Apr;18(2):184-91. doi: 10.1055/s-0033-1352504. Epub 2013 Nov 05. PMID: 25992088; PMCID: PMC4297018.
Copy Download .nbib Format: NLM
Effects of proton pump inhibitors on vitamin B12.

Maturitas

Wilhelm SM, Kale-Pradhan PB.
PMID: 24996485
Maturitas. 2014 Sep;79(1):1-2. doi: 10.1016/j.maturitas.2014.06.005. Epub 2014 Jun 14.

No abstract available.

Cite
Wilhelm SM, Kale-Pradhan PB. Effects of proton pump inhibitors on vitamin B12. Maturitas. 2014;79(1):1-2doi: 10.1016/j.maturitas.2014.06.005.
Wilhelm, S. M., & Kale-Pradhan, P. B. (2014). Effects of proton pump inhibitors on vitamin B12. Maturitas, 79(1), 1-2. https://doi.org/10.1016/j.maturitas.2014.06.005
Wilhelm, Sheila M, and Kale-Pradhan, Pramodini B. "Effects of proton pump inhibitors on vitamin B12." Maturitas vol. 79,1 (2014): 1-2. doi: https://doi.org/10.1016/j.maturitas.2014.06.005
Wilhelm SM, Kale-Pradhan PB. Effects of proton pump inhibitors on vitamin B12. Maturitas. 2014 Sep;79(1):1-2. doi: 10.1016/j.maturitas.2014.06.005. Epub 2014 Jun 14. PMID: 24996485.
Copy Download .nbib Format: NLM
Recombinogenic activity of Pantoprazole(®) in somatic cells of Drosophila melanogaster.

Genetics and molecular biology

Lopes JC, Machado NM, Saturnino RS, Nepomuceno JC.
PMID: 25983631
Genet Mol Biol. 2015 Mar;38(1):101-6. doi: 10.1590/S1415-475738120140154. Epub 2014 Mar 17.

Pantoprazole(®) is one of the leading proton pump inhibitors (PPIs) used in the treatment of a variety of diseases related to the upper gastrointestinal tract. However, studies have shown an increased risk of developing gastric cancer, intestinal metaplasia and...

Cite
Lopes JC, Machado NM, Saturnino RS, et al. Recombinogenic activity of Pantoprazole(®) in somatic cells of Drosophila melanogaster. Genet Mol Biol. 2014;38(1):101-6doi: 10.1590/S1415-475738120140154.
Lopes, J. C., Machado, N. M., Saturnino, R. S., & Nepomuceno, J. C. (2015). Recombinogenic activity of Pantoprazole(®) in somatic cells of Drosophila melanogaster. Genetics and molecular biology, 38(1), 101-6. https://doi.org/10.1590/S1415-475738120140154
Lopes, Jeyson Césary, et al. "Recombinogenic activity of Pantoprazole(®) in somatic cells of Drosophila melanogaster." Genetics and molecular biology vol. 38,1 (2015): 101-6. doi: https://doi.org/10.1590/S1415-475738120140154
Lopes JC, Machado NM, Saturnino RS, Nepomuceno JC. Recombinogenic activity of Pantoprazole(®) in somatic cells of Drosophila melanogaster. Genet Mol Biol. 2015 Mar;38(1):101-6. doi: 10.1590/S1415-475738120140154. Epub 2014 Mar 17. PMID: 25983631; PMCID: PMC4415568.
Copy Download .nbib Format: NLM
An Overview of the Diagnosis and Management of Eosinophilic Esophagitis.

Clinical and translational gastroenterology

Singla MB, Moawad FJ.
PMID: 26986655
Clin Transl Gastroenterol. 2016 Mar 17;7:e155. doi: 10.1038/ctg.2016.4.

Eosinophilic esophagitis (EoE) is a chronic inflammatory condition characterized by symptoms of esophageal dysfunction and eosinophilic infiltration of the esophageal mucosa. The diagnosis requires esophageal biopsies demonstrating at least 15 eosinophils per high-powered field following a course of high-dose...

Cite
Singla MB, Moawad FJ. An Overview of the Diagnosis and Management of Eosinophilic Esophagitis. Clin Transl Gastroenterol. 2016;7:e155doi: 10.1038/ctg.2016.4.
Singla, M. B., & Moawad, F. J. (2016). An Overview of the Diagnosis and Management of Eosinophilic Esophagitis. Clinical and translational gastroenterology, 7e155. https://doi.org/10.1038/ctg.2016.4
Singla, Manish B, and Moawad, Fouad J. "An Overview of the Diagnosis and Management of Eosinophilic Esophagitis." Clinical and translational gastroenterology vol. 7 (2016): e155. doi: https://doi.org/10.1038/ctg.2016.4
Singla MB, Moawad FJ. An Overview of the Diagnosis and Management of Eosinophilic Esophagitis. Clin Transl Gastroenterol. 2016 Mar 17;7:e155. doi: 10.1038/ctg.2016.4. PMID: 26986655; PMCID: PMC4822098.
Copy Download .nbib Format: NLM
Combination Use of Clopidogrel and Proton Pump Inhibitors Increases Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease: A Meta-Analysis.

Journal of cardiovascular pharmacology and therapeutics

Niu Q, Wang Z, Zhang Y, Wang J, Zhang P, Wang C, Yin X, Hou Y.
PMID: 27512080
J Cardiovasc Pharmacol Ther. 2017 Mar;22(2):142-152. doi: 10.1177/1074248416663647. Epub 2016 Aug 20.

BACKGROUND: Published data indicated that combination use of clopidogrel and proton pump inhibitors (PPIs) may increase the incidence of major adverse cardiovascular events (MACEs). This has been a highly controversial topic for years.DESIGN: The present study was performed to...

Cite
Niu Q, Wang Z, Zhang Y, et al. Combination Use of Clopidogrel and Proton Pump Inhibitors Increases Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease: A Meta-Analysis. J Cardiovasc Pharmacol Ther. 2016;22(2):142-152doi: 10.1177/1074248416663647.
Niu, Q., Wang, Z., Zhang, Y., Wang, J., Zhang, P., Wang, C., Yin, X., & Hou, Y. (2017). Combination Use of Clopidogrel and Proton Pump Inhibitors Increases Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease: A Meta-Analysis. Journal of cardiovascular pharmacology and therapeutics, 22(2), 142-152. https://doi.org/10.1177/1074248416663647
Niu, Qiang, et al. "Combination Use of Clopidogrel and Proton Pump Inhibitors Increases Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease: A Meta-Analysis." Journal of cardiovascular pharmacology and therapeutics vol. 22,2 (2017): 142-152. doi: https://doi.org/10.1177/1074248416663647
Niu Q, Wang Z, Zhang Y, Wang J, Zhang P, Wang C, Yin X, Hou Y. Combination Use of Clopidogrel and Proton Pump Inhibitors Increases Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease: A Meta-Analysis. J Cardiovasc Pharmacol Ther. 2017 Mar;22(2):142-152. doi: 10.1177/1074248416663647. Epub 2016 Aug 20. PMID: 27512080.
Copy Download .nbib Format: NLM
Relationship between cytochrome P450 polymorphisms and prescribed medication in elderly haemodialysis patients.

SpringerPlus

Parker K, Aasebø W, Haslemo T, Stavem K.
PMID: 27066364
Springerplus. 2016 Mar 22;5:350. doi: 10.1186/s40064-016-1986-y. eCollection 2016.

BACKGROUND: Elderly patients on haemodialysis have a high prevalence of polypharmacy and are at risk of drug-related complications. More than 80 % of all prescribed drugs are metabolized by the cytochrome P450 (CYP) enzyme system. The aims of this...

Cite
Parker K, Aasebø W, Haslemo T, et al. Relationship between cytochrome P450 polymorphisms and prescribed medication in elderly haemodialysis patients. Springerplus. 2016;5:350doi: 10.1186/s40064-016-1986-y.
Parker, K., Aasebø, W., Haslemo, T., & Stavem, K. (2016). Relationship between cytochrome P450 polymorphisms and prescribed medication in elderly haemodialysis patients. SpringerPlus, 5350. https://doi.org/10.1186/s40064-016-1986-y
Parker, Krystina, et al. "Relationship between cytochrome P450 polymorphisms and prescribed medication in elderly haemodialysis patients." SpringerPlus vol. 5 (2016): 350. doi: https://doi.org/10.1186/s40064-016-1986-y
Parker K, Aasebø W, Haslemo T, Stavem K. Relationship between cytochrome P450 polymorphisms and prescribed medication in elderly haemodialysis patients. Springerplus. 2016 Mar 22;5:350. doi: 10.1186/s40064-016-1986-y. eCollection 2016. PMID: 27066364; PMCID: PMC4801827.
Copy Download .nbib Format: NLM
Immunosuppressive agents are associated with peptic ulcer bleeding.

Experimental and therapeutic medicine

Tomizawa M, Shinozaki F, Hasegawa R, Shirai Y, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.
PMID: 28565788
Exp Ther Med. 2017 May;13(5):1927-1931. doi: 10.3892/etm.2017.4214. Epub 2017 Mar 09.

Peptic ulcer bleeding can be fatal. Non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids and immunosuppressive agents are administered for long-term usage. The present study assessed the association between peptic ulcer bleeding and administration of NSAIDs, corticosteroids and immunosuppressive agents. Furthermore, the...

Cite
Tomizawa M, Shinozaki F, Hasegawa R, et al. Immunosuppressive agents are associated with peptic ulcer bleeding. Exp Ther Med. 2017;13(5):1927-1931doi: 10.3892/etm.2017.4214.
Tomizawa, M., Shinozaki, F., Hasegawa, R., Shirai, Y., Motoyoshi, Y., Sugiyama, T., Yamamoto, S., & Ishige, N. (2017). Immunosuppressive agents are associated with peptic ulcer bleeding. Experimental and therapeutic medicine, 13(5), 1927-1931. https://doi.org/10.3892/etm.2017.4214
Tomizawa, Minoru, et al. "Immunosuppressive agents are associated with peptic ulcer bleeding." Experimental and therapeutic medicine vol. 13,5 (2017): 1927-1931. doi: https://doi.org/10.3892/etm.2017.4214
Tomizawa M, Shinozaki F, Hasegawa R, Shirai Y, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N. Immunosuppressive agents are associated with peptic ulcer bleeding. Exp Ther Med. 2017 May;13(5):1927-1931. doi: 10.3892/etm.2017.4214. Epub 2017 Mar 09. PMID: 28565788; PMCID: PMC5443275.
Copy Download .nbib Format: NLM
Effect of electrical stimulation of the lower esophageal sphincter in gastroesophageal reflux disease patients refractory to proton pump inhibitors.

World journal of gastrointestinal pharmacology and therapeutics

Soffer E, Rodríguez L, Rodriguez P, Gómez B, Neto MG, Crowell MD.
PMID: 26855821
World J Gastrointest Pharmacol Ther. 2016 Feb 06;7(1):145-55. doi: 10.4292/wjgpt.v7.i1.145.

AIM: To evaluate the efficacy of lower esophageal sphincter (LES)-electrical stimulation therapy (EST) in a subgroup of patients that reported only partial response to proton pump inhibitors (PPIs) therapy, compared to a group of patient with complete response.METHODS: Bipolar...

Cite
Soffer E, Rodríguez L, Rodriguez P, et al. Effect of electrical stimulation of the lower esophageal sphincter in gastroesophageal reflux disease patients refractory to proton pump inhibitors. World J Gastrointest Pharmacol Ther. 2016;7(1):145-55doi: 10.4292/wjgpt.v7.i1.145.
Soffer, E., Rodríguez, L., Rodriguez, P., Gómez, B., Neto, M. G., & Crowell, M. D. (2016). Effect of electrical stimulation of the lower esophageal sphincter in gastroesophageal reflux disease patients refractory to proton pump inhibitors. World journal of gastrointestinal pharmacology and therapeutics, 7(1), 145-55. https://doi.org/10.4292/wjgpt.v7.i1.145
Soffer, Edy, et al. "Effect of electrical stimulation of the lower esophageal sphincter in gastroesophageal reflux disease patients refractory to proton pump inhibitors." World journal of gastrointestinal pharmacology and therapeutics vol. 7,1 (2016): 145-55. doi: https://doi.org/10.4292/wjgpt.v7.i1.145
Soffer E, Rodríguez L, Rodriguez P, Gómez B, Neto MG, Crowell MD. Effect of electrical stimulation of the lower esophageal sphincter in gastroesophageal reflux disease patients refractory to proton pump inhibitors. World J Gastrointest Pharmacol Ther. 2016 Feb 06;7(1):145-55. doi: 10.4292/wjgpt.v7.i1.145. PMID: 26855821; PMCID: PMC4734948.
Copy Download .nbib Format: NLM
Erratum to: Bone density in proton pump inhibitors users: a prospective study.

Rheumatology international

Ozdil K, Kahraman R, Sahin A, Calhan T, Gozden EH, Akyuz U, Erer B, Sokmen MH.
PMID: 27553689
Rheumatol Int. 2016 Oct;36(10):1479. doi: 10.1007/s00296-016-3554-8.

No abstract available.

Cite
Ozdil K, Kahraman R, Sahin A, et al. Erratum to: Bone density in proton pump inhibitors users: a prospective study. Rheumatol Int. 2016;36(10):1479doi: 10.1007/s00296-016-3554-8.
Ozdil, K., Kahraman, R., Sahin, A., Calhan, T., Gozden, E. H., Akyuz, U., Erer, B., & Sokmen, M. H. (2016). Erratum to: Bone density in proton pump inhibitors users: a prospective study. Rheumatology international, 36(10), 1479. https://doi.org/10.1007/s00296-016-3554-8
Ozdil, Kamil, et al. "Erratum to: Bone density in proton pump inhibitors users: a prospective study." Rheumatology international vol. 36,10 (2016): 1479. doi: https://doi.org/10.1007/s00296-016-3554-8
Ozdil K, Kahraman R, Sahin A, Calhan T, Gozden EH, Akyuz U, Erer B, Sokmen MH. Erratum to: Bone density in proton pump inhibitors users: a prospective study. Rheumatol Int. 2016 Oct;36(10):1479. doi: 10.1007/s00296-016-3554-8. PMID: 27553689.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 1722 entries